Teladoc exec sells 6,200 shares after RSU vest
Teladoc Health’s President, International had RSUs vest into shares, then sold 6,200 shares to satisfy tax withholding obligations.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Teladoc Health, Inc. (TDOC) reported that Carlos Nueno, President, International, had restricted stock units convert into a total of 13,273 shares of common stock on September 1, 2026, on a one-for-one basis. On September 2, 2026, he sold 6,200 shares at $6.301 per share, and a footnote states these shares were sold to cover the tax withholding obligation arising from the RSU vesting. No Rule 10b5-1 trading plan is reported.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
5 txns
Insider
Nueno Carlos
Role
President, International
Sold
6,200 shs ($39K)
Approx. gross sale proceeds
$39K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F2 | 6,200 | $6.301 | $39K |
| Exercise | Restricted Stock Units F1, F3 | 4,556 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F1, F4 | 8,717 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 4,556 | -- | -- |
| Exercise | Common Stock F1 | 8,717 | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 61,416 contracts (Direct);
Common Stock — 64,744 shares (Direct)
Footnotes (4)
- F1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- F2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
- F3. On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
- F4. On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Key Figures
Shares sold: 6,200 shares
Sale price: $6.301 per share
RSUs converted: 13,273 units
+2 more
5 metrics
Shares sold
6,200 shares
Common stock sale on September 2, 2026 to cover tax withholding
Sale price
$6.301 per share
Price for 6,200 Teladoc common shares sold on September 2, 2026
RSUs converted
13,273 units
Restricted stock units converting into common stock on September 1, 2026
RSU grant 2024
54,675 units
RSUs granted March 19, 2024 with staged vesting
RSU grant 2025
104,602 units
RSUs granted March 1, 2025 with staged vesting
Key Terms
Restricted stock units, tax withholding obligation, vesting, Rule 10b5-1
4 terms
Restricted stock units financial
"On March 19, 2024, the reporting person was granted 54,675 restricted stock units,"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligation financial
"Shares sold to cover the tax withholding obligation in respect of vesting"
vesting financial
"vesting one-third on the first anniversary of the grant date, with the remainder"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Rule 10b5-1 regulatory
"No Rule 10b5-1 trading plan is reported for these transactions"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Teladoc Health (TDOC) insider Carlos Nueno report in this Form 4?
He reported RSUs converting into 13,273 shares of Teladoc Health common stock on September 1, 2026, followed by a sale of 6,200 shares on September 2, 2026 primarily to cover tax withholding obligations from the vesting.
How many Teladoc Health (TDOC) RSUs vested or converted for Carlos Nueno?
A total of 13,273 restricted stock units converted into 13,273 shares of Teladoc Health common stock on September 1, 2026, reflecting a one-for-one conversion ratio disclosed in the filing’s footnotes.
Were Carlos Nueno’s Teladoc (TDOC) transactions under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as affirming a plan, and the footnotes do not state that the transactions were made pursuant to a Rule 10b5-1 trading plan.
What Teladoc (TDOC) equity awards are referenced in Carlos Nueno’s Form 4 footnotes?
Footnotes describe RSU grants of 54,675 units on March 19, 2024 and 104,602 units on March 1, 2025, each vesting one-third on the first anniversary (or March 1, 2026) with the remainder vesting in eight substantially equal quarterly installments.
AI-generated analysis. How Rhea-AI works. Not financial advice.
